These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 33337787)

  • 1. Is Tranexamic Acid Associated With Mortality or Multiple Organ Failure Following Severe Injury?
    Richards JE; Fedeles BT; Chow JH; Morrison JJ; Renner C; Trinh AT; Schlee CS; Koerner K; Grissom TE; Betzold RD; Scalea TM; Kozar RA
    Shock; 2021 Jan; 55(1):55-60. PubMed ID: 33337787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis.
    Moore HB; Moore EE; Huebner BR; Stettler GR; Nunns GR; Einersen PM; Silliman CC; Sauaia A
    J Surg Res; 2017 Dec; 220():438-443. PubMed ID: 28755903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of fibrinolysis phenotype with patient outcomes following traumatic brain injury.
    Durbin S; Brito A; Johnson A; Cotton B; Rowell S; Schreiber MA
    J Trauma Acute Care Surg; 2024 Mar; 96(3):482-486. PubMed ID: 37700441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harmful or Physiologic: Diagnosing Fibrinolysis Shutdown in a Trauma Cohort With Rotational Thromboelastometry.
    Gomez-Builes JC; Acuna SA; Nascimento B; Madotto F; Rizoli SB
    Anesth Analg; 2018 Oct; 127(4):840-849. PubMed ID: 29683829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Tranexamic Acid in Prehospital Traumatic Hemorrhagic Shock: Outcomes of the Cal-PAT Study.
    Neeki MM; Dong F; Toy J; Vaezazizi R; Powell J; Jabourian N; Jabourian A; Wong D; Vara R; Seiler K; Pennington TW; Powell J; Yoshida-McMath C; Kissel S; Schulz-Costello K; Mistry J; Surrusco MS; O'Bosky KR; Van Stralen D; Ludi D; Sporer K; Benson P; Kwong E; Pitts R; Culhane JT; Borger R
    West J Emerg Med; 2017 Jun; 18(4):673-683. PubMed ID: 28611888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of fibrinolytic shutdown in trauma patients with traumatic brain injury.
    Favors L; Harrell K; Miles V; Hicks RC; Rippy M; Parmer H; Edwards A; Brown C; Stewart K; Day L; Wilson A; Maxwell R
    Am J Surg; 2024 Jan; 227():72-76. PubMed ID: 37802703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator.
    Moore HB; Moore EE; Huebner BR; Dzieciatkowska M; Stettler GR; Nunns GR; Lawson PJ; Ghasabyan A; Chandler J; Banerjee A; Silliman C; Sauaia A; Hansen KC
    J Trauma Acute Care Surg; 2017 Dec; 83(6):1014-1022. PubMed ID: 29190254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating Pathologic from Physiologic Fibrinolysis: Not as Simple as Conventional Thrombelastography.
    Moore HB; Barrett CD; Moore EE; Pieracci FM; Sauaia A
    J Am Coll Surg; 2024 Jul; 239(1):30-41. PubMed ID: 38299576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between tranexamic acid administration and mortality based on the trauma phenotype: a retrospective analysis of a nationwide trauma registry in Japan.
    Tachino J; Seno S; Matsumoto H; Kitamura T; Hirayama A; Nakao S; Katayama Y; Ogura H; Oda J
    Crit Care; 2024 Mar; 28(1):89. PubMed ID: 38504320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible effect of the early administration of tranexamic acid on myocardial injury in patients with severe trauma.
    Stroda A; Thelen S; M'Pembele R; Tenge T; Jaekel C; Schiffner E; Bieler D; Bernhard M; Huhn R; Lurati Buse G; Roth S
    J Thromb Thrombolysis; 2024 Feb; 57(2):179-185. PubMed ID: 37839024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular administration of tranexamic acid in a large swine model of hemorrhage with hyperfibrinolysis.
    Haberkorn CJ; Severance CC; Wetmore NC; West WG; Ng PC; Cendali F; Pitotti C; Schauer SG; Maddry JK; Bebarta VS; Hendry-Hofer TB
    J Trauma Acute Care Surg; 2024 May; 96(5):735-741. PubMed ID: 37962201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranexamic acid in trauma: After 3 hours from injury, when is it safe and effective to use again?
    Barrett CD; Neal MD; Schoenecker JG; Medcalf RL; Myles PS
    Transfusion; 2024 May; 64 Suppl 2():S11-S13. PubMed ID: 38461482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-of-care testing for tranexamic acid efficacy: a proof-of-concept study in cardiac surgical patients.
    Yoshii R; Takahashi Y; Tanaka KA; Kawajiri H; Sawa T; Amaya F; Ogawa S
    Br J Anaesth; 2024 Jun; 132(6):1211-1218. PubMed ID: 38677950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative analysis of tranexamic acid dosing strategies in traumatic major hemorrhage.
    Gunn F; Stevenson R; Almuwallad A; Rossetto A; Vulliamy P; Brohi K; Davenport R
    J Trauma Acute Care Surg; 2024 Feb; 96(2):216-224. PubMed ID: 37872678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin-based oxygen carriers promote systemic hyperfibrinolysis that is both dependent and independent of plasmin.
    Morton AP; Moore EE; Moore HB; Gonzalez E; Chapman MP; Peltz E; Banerjee A; Silliman C
    J Surg Res; 2017 Jun; 213():166-170. PubMed ID: 28601310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the BATT score for prehospital risk stratification of traumatic haemorrhagic death: usefulness for tranexamic acid treatment criteria.
    Ageron FX; Coats TJ; Darioli V; Roberts I
    Scand J Trauma Resusc Emerg Med; 2021 Jan; 29(1):6. PubMed ID: 33407716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide analysis of prehospital tranexamic acid for trauma demonstrates systematic bias in adherence to treatment guidelines: a retrospective cohort study.
    Almuwallad A; Cole E; Rossetto A; Brohi K; Perkins Z; Davenport R
    Int J Surg; 2023 Dec; 109(12):3796-3803. PubMed ID: 37720941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia.
    Ilich A; Gernsheimer TB; Triulzi DJ; Herren H; Brown SP; Holle LA; Lucas AT; de Laat B; El Kassar N; Wolberg AS; May S; Key NS
    Blood Adv; 2023 Mar; 7(6):900-908. PubMed ID: 36044391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-hospital tranexamic acid administration in patients with a severe hemorrhage: an evaluation after the implementation of tranexamic acid administration in the Dutch pre-hospital protocol.
    Gulickx M; Lokerman RD; Waalwijk JF; Dercksen B; van Wessem KJP; Tuinema RM; Leenen LPH; van Heijl M
    Eur J Trauma Emerg Surg; 2024 Feb; 50(1):139-147. PubMed ID: 37067552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Nebulized Tranexamic Acid in Patients with Moderate-to-Massive Hemoptysis at a Tertiary Academic Medical Center.
    Alkazemi A; Kovacevic M; Dube K; Lauffenburger JC; Smith A; Malinowski S; Weinhouse GL
    J Aerosol Med Pulm Drug Deliv; 2023 Dec; 36(6):309-315. PubMed ID: 37962861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.